Filing Details
- Accession Number:
- 0001209191-23-045234
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-09 18:21:38
- Reporting Period:
- 2023-08-08
- Accepted Time:
- 2023-08-09 18:21:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662774 | Quince Therapeutics Inc. | QNCX | Biological Products, (No Disgnostic Substances) (2836) | 901024039 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1929422 | Brendan Hannah | C/O Cortexyme, Inc. 601 Gateway Blvd, #1250 South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-08 | 71,762 | $1.22 | 201,555 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
